These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35471724)

  • 1. Correction to: Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
    Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
    Neurotox Res; 2022 Jun; 40(3):909-910. PubMed ID: 35471724
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
    Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
    Neurotox Res; 2022 Feb; 40(1):215-229. PubMed ID: 34817799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone and elevated extracellular potassium concentration induce cell-specific fibrillation of α-synuclein in axons of cholinergic enteric neurons in the guinea-pig ileum.
    Sharrad DF; Chen BN; Gai WP; Vaikath N; El-Agnaf OM; Brookes SJ
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27997067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomorphological Changes in the Olfactory Bulbs of Rats after Intranasal Administration of Rotenone.
    Voronkov DN; Kutukova KA; Ivanov MV; Khudoerkov RM
    Bull Exp Biol Med; 2017 Dec; 164(2):203-206. PubMed ID: 29181664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
    Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
    Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
    Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
    J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-(1-7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson's disease.
    Gao Q; Chen R; Wu L; Huang Q; Wang XX; Tian YY; Zhang YD
    Neural Regen Res; 2022 May; 17(5):1138-1145. PubMed ID: 34558543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.
    De Miranda BR; Fazzari M; Rocha EM; Castro S; Greenamyre JT
    Toxicol Sci; 2019 Jul; 170(1):133-143. PubMed ID: 30907971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
    Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
    Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
    Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
    J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo.
    Van Laar VS; Chen J; Zharikov AD; Bai Q; Di Maio R; Dukes AA; Hastings TG; Watkins SC; Greenamyre JT; St Croix CM; Burton EA
    Redox Biol; 2020 Oct; 37():101695. PubMed ID: 32905883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Neuroscience; 2012 Feb; 203():170-9. PubMed ID: 22198020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
    George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
    J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Sharma SK; Ebadi M
    Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
    Miyazaki I; Isooka N; Imafuku F; Sun J; Kikuoka R; Furukawa C; Asanuma M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    De Miranda BR; Rocha EM; Bai Q; El Ayadi A; Hinkle D; Burton EA; Timothy Greenamyre J
    Neurobiol Dis; 2018 Jul; 115():101-114. PubMed ID: 29649621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model.
    Huang J; Yang J; Shen Y; Jiang H; Han C; Zhang G; Liu L; Xu X; Li J; Lin Z; Xiong N; Zhang Z; Xiong J; Wang T
    Front Mol Neurosci; 2017; 10():13. PubMed ID: 28197072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.